HSIC Henry Schein
FY2024 10-K
Filed: Feb 25, 2025
Consumer Discretionary
Wholesale-Medical, Dental & Hospital Equipment & SuppliesSEC EDGAR Henry Schein (HSIC) filed its fiscal year 2024 10-K annual report with the SEC on Feb 25, 2025. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.
AI Filing AnalysisFY2024 10-K
Business Overview
- • Core business model: Global distributor and manufacturer of dental, medical, specialty healthcare products, and practice management technologies
- • New segment reporting structure in 2024: three segments — Global Distribution and Value-Added Services, Global Specialty Products, Global Technology
Management Discussion & Analysis
- • Revenue $12.339B, down 2.4% YoY; Global Dental flat at $6.65B (+0.3%), Global Medical down 10% to $3.91B
- • Gross margin 31.7% vs 31.3%; Global Specialty Products margin 54.1% vs 53.3%, Global Technology margin 67.4% vs 69.2%, Global Distribution margin 25.6% vs 25.2%
Risk Factors
- • Regulatory risk: non-compliance with EU Medical Device Regulation impacting global specialty products manufacturing
- • Geopolitical risk: disruptions from ongoing wars including Ukraine and Israel-Gaza conflicts affecting international trade and operations
Financial SummaryXBRL
Revenue
$12.7B
Net Income
$390M
Gross Margin
31.7%
Operating Margin
4.9%
Net Margin
3.1%
ROE
11.5%
Total Assets
$10.2B
EPS (Diluted)
$3.05
Operating Cash Flow
$848M
Source: XBRL data from Henry Schein FY2024 10-K filing on SEC EDGAR. All figures in USD.
Other Henry Schein Annual Reports
Get deeper insights on Henry Schein
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.